Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria

Background: According to the Response Assessment in Neurooncology (RANO) criteria, significant nonenhancing signal increase in T2-weighted images qualifies for progression in high-grade glioma (T2-progress), even if there is no change in the contrast-enhancing tumor portion. The purpose of this retr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Radbruch, Alexander (VerfasserIn) , Lutz, Kira (VerfasserIn) , Wiestler, Benedikt (VerfasserIn) , Bäumer, Philipp (VerfasserIn) , Heiland, Sabine (VerfasserIn) , Wick, Wolfgang (VerfasserIn) , Bendszus, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2012
In: Neuro-Oncology
Year: 2012, Jahrgang: 14, Heft: 2, Pages: 222-229
ISSN:1523-5866
DOI:10.1093/neuonc/nor200
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1093/neuonc/nor200
Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/14/2/222/1038873
Volltext
Verfasserangaben:Alexander Radbruch, Kira Lutz, Benedikt Wiestler, Philipp Bäumer, Sabine Heiland, Wolfgang Wick, and Martin Bendszus

MARC

LEADER 00000caa a2200000 c 4500
001 1584416211
003 DE-627
005 20230427161327.0
007 cr uuu---uuuuu
008 181126s2012 xx |||||o 00| ||eng c
024 7 |a 10.1093/neuonc/nor200  |2 doi 
035 |a (DE-627)1584416211 
035 |a (DE-576)514416211 
035 |a (DE-599)BSZ514416211 
035 |a (OCoLC)1341024289 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Radbruch, Alexander  |d 1977-  |e VerfasserIn  |0 (DE-588)1022344501  |0 (DE-627)716953951  |0 (DE-576)362851166  |4 aut 
245 1 0 |a Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria  |c Alexander Radbruch, Kira Lutz, Benedikt Wiestler, Philipp Bäumer, Sabine Heiland, Wolfgang Wick, and Martin Bendszus 
264 1 |c February 2012 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Advance access publication December 6, 2011 
500 |a Gesehen am 26.11.2018 
520 |a Background: According to the Response Assessment in Neurooncology (RANO) criteria, significant nonenhancing signal increase in T2-weighted images qualifies for progression in high-grade glioma (T2-progress), even if there is no change in the contrast-enhancing tumor portion. The purpose of this retrospective study was to assess the frequency of isolated T2-progress and its predictive value on subsequent T1-progress, as determined by a T2 signal increase of 15% or 25%, respectively. The frequency of T2-progress was correlated with antiangiogenic therapy. Patients and Methods: MRI follow-up examinations (n = 777) of 144 patients with histologically proven glioblastoma were assessed for contrast-enhanced T1 and T2-weighted images. Examinations were classified as T1-progress, T2-progress with 15% or 25% T2-signal increase, stable disease, or partial or complete response. Results: Thirty-five examinations revealed exclusive T2-progress using the 15% criterion, and only 2 examinations qualified for the 25% criterion; 61.8% of the scans presenting T2-progress and 31.5% of the scans presenting stable disease revealed T1-progress in the next follow-up examination. The χ2 test showed a highly significant correlation (P < .001) between T2-progress, with the 15% criterion and subsequent T1-progress. No correlation between antiangiogenic therapy and T2-progress was shown. Conclusion: Tumor progression, as determined by both contrast-enhanced T1 and T2 sequences is more frequently diagnosed than when considering only contrast-enhanced T1 sequences. Definition of T2-progress by a 15% T2-signal increase criterion is superior to a 25% criterion. The missing correlation of T2-progress and antiangiogenic therapy supports the hypothesis of T2-progress as part of the natural course of the tumor disease. 
700 1 |a Lutz, Kira  |d 1980-  |e VerfasserIn  |0 (DE-588)132632608  |0 (DE-627)524708312  |0 (DE-576)259887277  |4 aut 
700 1 |a Wiestler, Benedikt  |d 1983-  |e VerfasserIn  |0 (DE-588)1014415837  |0 (DE-627)705225879  |0 (DE-576)348205139  |4 aut 
700 1 |a Bäumer, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)138369836  |0 (DE-627)696555735  |0 (DE-576)307128032  |4 aut 
700 1 |a Heiland, Sabine  |e VerfasserIn  |0 (DE-588)106732626X  |0 (DE-627)818624450  |0 (DE-576)426561368  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Bendszus, Martin  |e VerfasserIn  |0 (DE-588)1032676426  |0 (DE-627)738634131  |0 (DE-576)175567697  |4 aut 
773 0 8 |i Enthalten in  |t Neuro-Oncology  |d Oxford : Oxford Univ. Press, 1999  |g 14(2012), 2, Seite 222-229  |h Online-Ressource  |w (DE-627)357167341  |w (DE-600)2094060-9  |w (DE-576)318041839  |x 1523-5866  |7 nnas  |a Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria 
773 1 8 |g volume:14  |g year:2012  |g number:2  |g pages:222-229  |g extent:8  |a Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria 
856 4 0 |u http://dx.doi.org/10.1093/neuonc/nor200  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/neuro-oncology/article/14/2/222/1038873  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181126 
993 |a Article 
994 |a 2012 
998 |g 1032676426  |a Bendszus, Martin  |m 1032676426:Bendszus, Martin  |d 910000  |d 911100  |e 910000PB1032676426  |e 911100PB1032676426  |k 0/910000/  |k 1/910000/911100/  |p 7  |y j 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 106732626X  |a Heiland, Sabine  |m 106732626X:Heiland, Sabine  |d 910000  |d 911100  |e 910000PH106732626X  |e 911100PH106732626X  |k 0/910000/  |k 1/910000/911100/  |p 5 
998 |g 138369836  |a Bäumer, Philipp  |m 138369836:Bäumer, Philipp  |d 910000  |d 911100  |e 910000PB138369836  |e 911100PB138369836  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 1014415837  |a Wiestler, Benedikt  |m 1014415837:Wiestler, Benedikt  |d 910000  |d 911100  |e 910000PW1014415837  |e 911100PW1014415837  |k 0/910000/  |k 1/910000/911100/  |p 3 
998 |g 132632608  |a Lutz, Kira  |m 132632608:Lutz, Kira  |p 2 
998 |g 1022344501  |a Radbruch, Alexander  |m 1022344501:Radbruch, Alexander  |d 910000  |d 911100  |e 910000PR1022344501  |e 911100PR1022344501  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1584416211  |e 3034030118 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Alexander Radbruch, Kira Lutz, Benedikt Wiestler, Philipp Bäumer, Sabine Heiland, Wolfgang Wick, and Martin Bendszus"]},"note":["Advance access publication December 6, 2011","Gesehen am 26.11.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"February 2012","dateIssuedKey":"2012"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"disp":"Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteriaNeuro-Oncology","language":["eng"],"id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1999 -"],"note":["Gesehen am 21.07.23"],"origin":[{"dateIssuedDisp":"1999-","publisher":"Oxford Univ. Press ; Duke University Medical Center","publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"2","pages":"222-229","volume":"14","year":"2012","extent":"8","text":"14(2012), 2, Seite 222-229"},"title":[{"title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology","title":"Neuro-Oncology"}],"recId":"357167341"}],"title":[{"title_sort":"Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria","title":"Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria"}],"language":["eng"],"id":{"doi":["10.1093/neuonc/nor200"],"eki":["1584416211"]},"person":[{"display":"Radbruch, Alexander","given":"Alexander","roleDisplay":"VerfasserIn","role":"aut","family":"Radbruch"},{"given":"Kira","roleDisplay":"VerfasserIn","display":"Lutz, Kira","family":"Lutz","role":"aut"},{"role":"aut","family":"Wiestler","display":"Wiestler, Benedikt","roleDisplay":"VerfasserIn","given":"Benedikt"},{"display":"Bäumer, Philipp","given":"Philipp","roleDisplay":"VerfasserIn","role":"aut","family":"Bäumer"},{"role":"aut","family":"Heiland","display":"Heiland, Sabine","given":"Sabine","roleDisplay":"VerfasserIn"},{"family":"Wick","role":"aut","roleDisplay":"VerfasserIn","given":"Wolfgang","display":"Wick, Wolfgang"},{"family":"Bendszus","role":"aut","roleDisplay":"VerfasserIn","given":"Martin","display":"Bendszus, Martin"}],"recId":"1584416211"} 
SRT |a RADBRUCHALRELEVANCEO2012